Report Detail

Pharma & Healthcare Global Biothrax (Anthrax Vaccine) Sales Market Report 2021

  • RnM4300391
  • |
  • 16 June, 2021
  • |
  • Global
  • |
  • 140 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

The global Biothrax (Anthrax Vaccine) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biothrax (Anthrax Vaccine) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Live Vaccines
Cell Free PA Vaccines

Segment by Application
Human Use
Animal Use

The Biothrax (Anthrax Vaccine) market is analysed and market size information is provided by regions (countries). Segment by Application, the Biothrax (Anthrax Vaccine) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Merial
Merck
Zoetis
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biogénesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Santé Animale
Intervac
JOVAC


1 Biothrax (Anthrax Vaccine) Market Overview

  • 1.1 Biothrax (Anthrax Vaccine) Product Scope
  • 1.2 Biothrax (Anthrax Vaccine) Segment by Type
    • 1.2.1 Global Biothrax (Anthrax Vaccine) Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 Live Vaccines
    • 1.2.3 Cell Free PA Vaccines
  • 1.3 Biothrax (Anthrax Vaccine) Segment by Application
    • 1.3.1 Global Biothrax (Anthrax Vaccine) Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Human Use
    • 1.3.3 Animal Use
  • 1.4 Biothrax (Anthrax Vaccine) Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Biothrax (Anthrax Vaccine) Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Biothrax (Anthrax Vaccine) Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Biothrax (Anthrax Vaccine) Price Trends (2016-2027)

2 Biothrax (Anthrax Vaccine) Estimates and Forecasts by Region

  • 2.1 Global Biothrax (Anthrax Vaccine) Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Biothrax (Anthrax Vaccine) Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Biothrax (Anthrax Vaccine) Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2016-2021)
  • 2.3 Global Biothrax (Anthrax Vaccine) Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Biothrax (Anthrax Vaccine) Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Biothrax (Anthrax Vaccine) Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Biothrax (Anthrax Vaccine) Estimates and Projections (2016-2027)
    • 2.4.2 Europe Biothrax (Anthrax Vaccine) Estimates and Projections (2016-2027)
    • 2.4.3 China Biothrax (Anthrax Vaccine) Estimates and Projections (2016-2027)
    • 2.4.4 Japan Biothrax (Anthrax Vaccine) Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Biothrax (Anthrax Vaccine) Estimates and Projections (2016-2027)
    • 2.4.6 India Biothrax (Anthrax Vaccine) Estimates and Projections (2016-2027)

3 Global Biothrax (Anthrax Vaccine) Competition Landscape by Players

  • 3.1 Global Top Biothrax (Anthrax Vaccine) Players by Sales (2016-2021)
  • 3.2 Global Top Biothrax (Anthrax Vaccine) Players by Revenue (2016-2021)
  • 3.3 Global Biothrax (Anthrax Vaccine) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biothrax (Anthrax Vaccine) as of 2020)
  • 3.4 Global Biothrax (Anthrax Vaccine) Average Price by Company (2016-2021)
  • 3.5 Manufacturers Biothrax (Anthrax Vaccine) Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Biothrax (Anthrax Vaccine) Market Size by Type

  • 4.1 Global Biothrax (Anthrax Vaccine) Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Biothrax (Anthrax Vaccine) Price by Type (2016-2021)
  • 4.2 Global Biothrax (Anthrax Vaccine) Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Biothrax (Anthrax Vaccine) Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Biothrax (Anthrax Vaccine) Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Biothrax (Anthrax Vaccine) Price Forecast by Type (2022-2027)

5 Global Biothrax (Anthrax Vaccine) Market Size by Application

  • 5.1 Global Biothrax (Anthrax Vaccine) Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Biothrax (Anthrax Vaccine) Price by Application (2016-2021)
  • 5.2 Global Biothrax (Anthrax Vaccine) Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Biothrax (Anthrax Vaccine) Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Biothrax (Anthrax Vaccine) Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Biothrax (Anthrax Vaccine) Price Forecast by Application (2022-2027)

6 North America Biothrax (Anthrax Vaccine) Market Facts & Figures

  • 6.1 North America Biothrax (Anthrax Vaccine) Sales by Company
    • 6.1.1 North America Biothrax (Anthrax Vaccine) Sales by Company (2016-2021)
    • 6.1.2 North America Biothrax (Anthrax Vaccine) Revenue by Company (2016-2021)
  • 6.2 North America Biothrax (Anthrax Vaccine) Sales Breakdown by Type
    • 6.2.1 North America Biothrax (Anthrax Vaccine) Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Biothrax (Anthrax Vaccine) Sales Breakdown by Type (2022-2027)
  • 6.3 North America Biothrax (Anthrax Vaccine) Sales Breakdown by Application
    • 6.3.1 North America Biothrax (Anthrax Vaccine) Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Biothrax (Anthrax Vaccine) Sales Breakdown by Application (2022-2027)

7 Europe Biothrax (Anthrax Vaccine) Market Facts & Figures

  • 7.1 Europe Biothrax (Anthrax Vaccine) Sales by Company
    • 7.1.1 Europe Biothrax (Anthrax Vaccine) Sales by Company (2016-2021)
    • 7.1.2 Europe Biothrax (Anthrax Vaccine) Revenue by Company (2016-2021)
  • 7.2 Europe Biothrax (Anthrax Vaccine) Sales Breakdown by Type
    • 7.2.1 Europe Biothrax (Anthrax Vaccine) Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Biothrax (Anthrax Vaccine) Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Biothrax (Anthrax Vaccine) Sales Breakdown by Application
    • 7.3.1 Europe 140 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 140 Sales Breakdown by Application (2022-2027)

8 China Biothrax (Anthrax Vaccine) Market Facts & Figures

  • 8.1 China Biothrax (Anthrax Vaccine) Sales by Company
    • 8.1.1 China Biothrax (Anthrax Vaccine) Sales by Company (2016-2021)
    • 8.1.2 China Biothrax (Anthrax Vaccine) Revenue by Company (2016-2021)
  • 8.2 China Biothrax (Anthrax Vaccine) Sales Breakdown by Type
    • 8.2.1 China Biothrax (Anthrax Vaccine) Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Biothrax (Anthrax Vaccine) Sales Breakdown by Type (2022-2027)
  • 8.3 China Biothrax (Anthrax Vaccine) Sales Breakdown by Application
    • 8.3.1 China 314 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 314 Sales Breakdown by Application (2022-2027)

9 Japan Biothrax (Anthrax Vaccine) Market Facts & Figures

  • 9.1 Japan Biothrax (Anthrax Vaccine) Sales by Company
    • 9.1.1 Japan Biothrax (Anthrax Vaccine) Sales by Company (2016-2021)
    • 9.1.2 Japan Biothrax (Anthrax Vaccine) Revenue by Company (2016-2021)
  • 9.2 Japan Biothrax (Anthrax Vaccine) Sales Breakdown by Type
    • 9.2.1 Japan Biothrax (Anthrax Vaccine) Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Biothrax (Anthrax Vaccine) Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Biothrax (Anthrax Vaccine) Sales Breakdown by Application
    • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Biothrax (Anthrax Vaccine) Market Facts & Figures

  • 10.1 Southeast Asia Biothrax (Anthrax Vaccine) Sales by Company
    • 10.1.1 Southeast Asia Biothrax (Anthrax Vaccine) Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Biothrax (Anthrax Vaccine) Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Biothrax (Anthrax Vaccine) Sales Breakdown by Type
    • 10.2.1 Southeast Asia Biothrax (Anthrax Vaccine) Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Biothrax (Anthrax Vaccine) Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Biothrax (Anthrax Vaccine) Sales Breakdown by Application
    • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Biothrax (Anthrax Vaccine) Market Facts & Figures

  • 11.1 India Biothrax (Anthrax Vaccine) Sales by Company
    • 11.1.1 India Biothrax (Anthrax Vaccine) Sales by Company (2016-2021)
    • 11.1.2 India Biothrax (Anthrax Vaccine) Revenue by Company (2016-2021)
  • 11.2 India Biothrax (Anthrax Vaccine) Sales Breakdown by Type
    • 11.2.1 India Biothrax (Anthrax Vaccine) Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Biothrax (Anthrax Vaccine) Sales Breakdown by Type (2022-2027)
  • 11.3 India Biothrax (Anthrax Vaccine) Sales Breakdown by Application
    • 11.3.1 India Biothrax (Anthrax Vaccine) Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Biothrax (Anthrax Vaccine) Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Biothrax (Anthrax Vaccine) Business

  • 12.1 Merial
    • 12.1.1 Merial Corporation Information
    • 12.1.2 Merial Business Overview
    • 12.1.3 Merial Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 Merial Biothrax (Anthrax Vaccine) Products Offered
    • 12.1.5 Merial Recent Development
  • 12.2 Merck
    • 12.2.1 Merck Corporation Information
    • 12.2.2 Merck Business Overview
    • 12.2.3 Merck Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Merck Biothrax (Anthrax Vaccine) Products Offered
    • 12.2.5 Merck Recent Development
  • 12.3 Zoetis
    • 12.3.1 Zoetis Corporation Information
    • 12.3.2 Zoetis Business Overview
    • 12.3.3 Zoetis Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Zoetis Biothrax (Anthrax Vaccine) Products Offered
    • 12.3.5 Zoetis Recent Development
  • 12.4 Bayer Sanidad Animal
    • 12.4.1 Bayer Sanidad Animal Corporation Information
    • 12.4.2 Bayer Sanidad Animal Business Overview
    • 12.4.3 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Products Offered
    • 12.4.5 Bayer Sanidad Animal Recent Development
  • 12.5 Colorado Serum
    • 12.5.1 Colorado Serum Corporation Information
    • 12.5.2 Colorado Serum Business Overview
    • 12.5.3 Colorado Serum Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Colorado Serum Biothrax (Anthrax Vaccine) Products Offered
    • 12.5.5 Colorado Serum Recent Development
  • 12.6 PharmAthene
    • 12.6.1 PharmAthene Corporation Information
    • 12.6.2 PharmAthene Business Overview
    • 12.6.3 PharmAthene Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 PharmAthene Biothrax (Anthrax Vaccine) Products Offered
    • 12.6.5 PharmAthene Recent Development
  • 12.7 Tiankang
    • 12.7.1 Tiankang Corporation Information
    • 12.7.2 Tiankang Business Overview
    • 12.7.3 Tiankang Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Tiankang Biothrax (Anthrax Vaccine) Products Offered
    • 12.7.5 Tiankang Recent Development
  • 12.8 Biogénesis-Bago
    • 12.8.1 Biogénesis-Bago Corporation Information
    • 12.8.2 Biogénesis-Bago Business Overview
    • 12.8.3 Biogénesis-Bago Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Biogénesis-Bago Biothrax (Anthrax Vaccine) Products Offered
    • 12.8.5 Biogénesis-Bago Recent Development
  • 12.9 CAVAC
    • 12.9.1 CAVAC Corporation Information
    • 12.9.2 CAVAC Business Overview
    • 12.9.3 CAVAC Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 CAVAC Biothrax (Anthrax Vaccine) Products Offered
    • 12.9.5 CAVAC Recent Development
  • 12.10 Rosenbusch
    • 12.10.1 Rosenbusch Corporation Information
    • 12.10.2 Rosenbusch Business Overview
    • 12.10.3 Rosenbusch Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 Rosenbusch Biothrax (Anthrax Vaccine) Products Offered
    • 12.10.5 Rosenbusch Recent Development
  • 12.11 Agrovet
    • 12.11.1 Agrovet Corporation Information
    • 12.11.2 Agrovet Business Overview
    • 12.11.3 Agrovet Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 Agrovet Biothrax (Anthrax Vaccine) Products Offered
    • 12.11.5 Agrovet Recent Development
  • 12.12 Vecol
    • 12.12.1 Vecol Corporation Information
    • 12.12.2 Vecol Business Overview
    • 12.12.3 Vecol Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
    • 12.12.4 Vecol Biothrax (Anthrax Vaccine) Products Offered
    • 12.12.5 Vecol Recent Development
  • 12.13 CVCRI
    • 12.13.1 CVCRI Corporation Information
    • 12.13.2 CVCRI Business Overview
    • 12.13.3 CVCRI Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
    • 12.13.4 CVCRI Biothrax (Anthrax Vaccine) Products Offered
    • 12.13.5 CVCRI Recent Development
  • 12.14 IVPM
    • 12.14.1 IVPM Corporation Information
    • 12.14.2 IVPM Business Overview
    • 12.14.3 IVPM Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
    • 12.14.4 IVPM Biothrax (Anthrax Vaccine) Products Offered
    • 12.14.5 IVPM Recent Development
  • 12.15 Prondil
    • 12.15.1 Prondil Corporation Information
    • 12.15.2 Prondil Business Overview
    • 12.15.3 Prondil Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
    • 12.15.4 Prondil Biothrax (Anthrax Vaccine) Products Offered
    • 12.15.5 Prondil Recent Development
  • 12.16 CDV
    • 12.16.1 CDV Corporation Information
    • 12.16.2 CDV Business Overview
    • 12.16.3 CDV Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
    • 12.16.4 CDV Biothrax (Anthrax Vaccine) Products Offered
    • 12.16.5 CDV Recent Development
  • 12.17 Indian Immunologicals
    • 12.17.1 Indian Immunologicals Corporation Information
    • 12.17.2 Indian Immunologicals Business Overview
    • 12.17.3 Indian Immunologicals Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
    • 12.17.4 Indian Immunologicals Biothrax (Anthrax Vaccine) Products Offered
    • 12.17.5 Indian Immunologicals Recent Development
  • 12.18 Botswana Vaccine Institute
    • 12.18.1 Botswana Vaccine Institute Corporation Information
    • 12.18.2 Botswana Vaccine Institute Business Overview
    • 12.18.3 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
    • 12.18.4 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Products Offered
    • 12.18.5 Botswana Vaccine Institute Recent Development
  • 12.19 Ceva Santé Animale
    • 12.19.1 Ceva Santé Animale Corporation Information
    • 12.19.2 Ceva Santé Animale Business Overview
    • 12.19.3 Ceva Santé Animale Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
    • 12.19.4 Ceva Santé Animale Biothrax (Anthrax Vaccine) Products Offered
    • 12.19.5 Ceva Santé Animale Recent Development
  • 12.20 Intervac
    • 12.20.1 Intervac Corporation Information
    • 12.20.2 Intervac Business Overview
    • 12.20.3 Intervac Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
    • 12.20.4 Intervac Biothrax (Anthrax Vaccine) Products Offered
    • 12.20.5 Intervac Recent Development
  • 12.21 JOVAC
    • 12.21.1 JOVAC Corporation Information
    • 12.21.2 JOVAC Business Overview
    • 12.21.3 JOVAC Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
    • 12.21.4 JOVAC Biothrax (Anthrax Vaccine) Products Offered
    • 12.21.5 JOVAC Recent Development

13 Biothrax (Anthrax Vaccine) Manufacturing Cost Analysis

  • 13.1 Biothrax (Anthrax Vaccine) Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Biothrax (Anthrax Vaccine)
  • 13.4 Biothrax (Anthrax Vaccine) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Biothrax (Anthrax Vaccine) Distributors List
  • 14.3 Biothrax (Anthrax Vaccine) Customers

15 Market Dynamics

  • 15.1 Biothrax (Anthrax Vaccine) Market Trends
  • 15.2 Biothrax (Anthrax Vaccine) Drivers
  • 15.3 Biothrax (Anthrax Vaccine) Market Challenges
  • 15.4 Biothrax (Anthrax Vaccine) Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    Summary:
    Get latest Market Research Reports on Biothrax (Anthrax Vaccine). Industry analysis & Market Report on Biothrax (Anthrax Vaccine) is a syndicated market report, published as Global Biothrax (Anthrax Vaccine) Sales Market Report 2021. It is complete Research Study and Industry Analysis of Biothrax (Anthrax Vaccine) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $4,000.00
    $6,000.00
    $8,000.00
    3,084.00
    4,626.00
    6,168.00
    3,704.00
    5,556.00
    7,408.00
    612,960.00
    919,440.00
    1,225,920.00
    337,320.00
    505,980.00
    674,640.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report